Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-14

Clinical Trial Update: Purified Rabies Vaccine for Human Use (Chick-embryo Cell) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a purified chick-embryo cell rabies vaccine for human use in rabies post-exposure prophylaxis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Purified Rabies Vaccine for Human Use (Chick-embryo Cell) (Purified chick embryo cell rabies vaccine)

Snippet

Sponsor: Novartis Vaccines | Conditions: Rabies Post-exposure Prophylaxis | Phase 3 | Status: COMPLETED